This article is available to subscribers. Subscribe now. Already have an account? Sign in

Original ArticleFree PreviewArchive

Relation between Complications of Type I Diabetes Mellitus and Collagen-Linked Fluorescence

List of authors.
  • Vincent M. Monnier, M.D.,
  • Vasanth Vishwanath, B.A.,
  • Kay E. Frank, M.D.,
  • Craig A. Elmets, M.D.,
  • Paul Dauchot, M.D.,
  • and Robert R. Kohn, Ph.D., M.D.*

Abstract

Nonenzymatically glycosylated proteins gradually form fluorescent cross-linked protein adducts — a process termed "browning." The rate of this reaction increases with the glucose concentration. Assaying for the presence of browning products in long-lived proteins should therefore provide information on long-term metabolic control.

We measured collagen-linked fluorescence typical for nonenzymatic browning in skin-biopsy specimens from 41 subjects with long-standing Type I diabetes and from 25 controls. Fluorescence correlated with age and (weakly) with the duration of diabetes. Mean age-adjusted fluorescence values were twice as high in diabetic subjects as in control subjects (P<0.0001) and increased with the severity of retinopathy, nephropathy, and arterial and joint stiffness. The correlation was significant for retinopathy (r = 0.42; P<0.01), arterial stiffness (r = 0.41; P<0.01), joint stiffness (r = 0.34; P<0.05), and the sum of all complications (r = 0.47; P<0.01). Fluorescence also correlated with systolic (r = 0.42; P<0.01) and diastolic (r = 0.36; P<0.05) blood pressures. If one can assume that the fluorescence results from a browning product of glucose, our data suggest that there is an overall correlation between the severity of diabetic complications and cumulative glycemia over many years. (N Engl J Med 1986; 314:403–8.)

Funding and Disclosures

Supported by a grant from The Kroc Foundation and in part by a grant from the Diabetes Association of Greater Cleveland. Drs. Monnier and Elmets are the recipients of New Investigator Awards from the National Eye Institute (EY 04803) and the National Institute of Arthritis, Metabolism and Digestive Diseases (AM 32593), respectively.

We are indebted to Ms. Suzanne Burton for skilled technical assistance, to Dr. Clive Hamlin and the staff of the Laboratory of Clinical Chemistry of University Hospitals for performing the laboratory tests, to Drs. William T. Dahms and Harvey M. Rodman for valuable discussions and a thorough review of the manuscript, to Dr. Toyoko Yamashita, Department of Epidemiology and Statistics, for statistical analysis, and to the Kroc Foundation, the Diabetes Association of Greater Cleveland, and the National Institutes of Health for their support and interest.

Author Affiliations

From the Departments of Pathology, Ophthalmology, Dermatology, and Anesthesiology, the School of Medicine, Case Western Reserve University, and the University Hospitals of Cleveland. Address reprint requests to Dr. Monnier at the Institute of Pathology, Case Western Reserve University, 2085 Adelbert Rd., Cleveland, OH 44106.

*Deceased, March 1984.

Print Subscriber? Activate your online access.